Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy

European Journal of Pharmacology
Qihang ZhangHarvey R Weiss

Abstract

We tested the hypothesis that the negative functional effects of cyclic GMP were mediated by ryanodine receptors, and that these effects would be reduced in thyroxine (thyroxine, 0.5 mg/kg/day, 16 days)-induced hypertrophic myocytes. Using rabbit ventricular myocytes from control (n=9) and thyroxine (n=9) hearts, percent cell shortening (%) and maximum rate of contraction and relaxation were determined using a video edge detector at baseline and after 10(-6), 10(-5) M 8-bromo-cyclic GMP. Dantrolene 10(-6) M, ryanodine receptor inhibitor, was added alone or after 8-Br-cGMP treatment. Changes in cytosolic Ca(2+) concentration were assessed in fura-2-loaded control and thyroxine myocytes. 8-Br-cGMP caused a significant decrease in percent shortening, from 5.3+/-0.9% to 3.9+/-0.6% at 10(-5 )M in control, and 3.4+/-0.3% to 2.6+/-0.4% in thyroxine myocytes. Dantrolene significantly decreased percent shortening from 4.5+/-0.8% to 3.7+/-0.1% in control and from 3.7+/-0.1% to 2.8+/-0.3% in thyroxine myocytes. In 8-Br-cGMP treated control myocytes, dantrolene did not significantly change myocyte contractility, which suggested that cyclic GMP acted on ryanodine receptors. However, in 8-Br-cGMP treated thyroxine myocytes, dantrolene furthe...Continue Reading

References

May 1, 1993·Circulation·R PolikarP Nicod
Aug 24, 1999·The Journal of Surgical Research·M W HuangP M Scholz
Apr 13, 2000·Pharmacology & Therapeutics·A M Shah, P A MacCarthy
Jun 30, 2000·Clinical Cardiology·B M FadelK D Burman
Mar 7, 2001·Biochemical Pharmacology·J P EuG Meissner
Aug 8, 2002·Thyroid : Official Journal of the American Thyroid Association·W H Dillmann
Aug 23, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·L W HuM L M Barreto-Chaves
Dec 4, 2003·Circulation Research·Renate B Pilz, Darren E Casteel
Dec 9, 2003·Trends in Biochemical Sciences·Xander H T Wehrens, Andrew R Marks
Dec 18, 2003·Clinical and Experimental Pharmacology & Physiology·Lin YanHarvey R Weiss
Feb 14, 2004·Basic Research in Cardiology·Gary F Baxter
Apr 28, 2004·Cell Calcium·Gerhard Meissner
Jun 2, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Tibor Kempf, Kai C Wollert
Jul 28, 2004·Journal of Molecular and Cellular Cardiology·Donald M Bers

❮ Previous
Next ❯

Citations

Aug 6, 2014·Chemico-biological Interactions·Liang ShiJianbao Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.